Sun Yat-sen University Cancer Center

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）	non-small cell lung carcinoma	Recruiting	Phase 3	2026-08-13		NCT07010419
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors	Solid Tumors	Recruiting	Phase 1 / Phase 2	2025-09-02		NCT04685226

Clinical trials